NCT05908526: A trial that was reported late by University of Maryland, Baltimore
This trial has reported, although it was 17 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05908526 |
|---|---|
| Title | The Impact of Suvorexant on Cognitive Function and Daytime Symptoms Among Community-dwelling Older Adults With Insomnia: A Placebo-controlled, Randomized Clinical Trial Using Remote Monitoring and Ecological Momentary Assessment |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 9, 2023 |
| Completion date | Aug. 8, 2024 |
| Required reporting date | Aug. 8, 2025, midnight |
| Actual reporting date | Aug. 25, 2025 |
| Date last checked at ClinicalTrials.gov | June 12, 2026 |
| Days late | 17 |